RXRX Annual Short Term Debt
$6.16 M
+$108.00 K+1.79%
31 December 2023
Summary:
As of January 23, 2025, RXRX annual short term debt is $6.16 million, with the most recent change of +$108.00 thousand (+1.79%) on December 31, 2023. During the last 3 years, it has risen by +$4.62 million (+299.81%). RXRX annual short term debt is now at all-time high.RXRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXRX Quarterly Short Term Debt
$16.45 M
-$264.00 K-1.58%
30 September 2024
Summary:
As of January 23, 2025, RXRX quarterly short term debt is $16.45 million, with the most recent change of -$264.00 thousand (-1.58%) on September 30, 2024. Over the past year, it has increased by +$10.34 million (+168.96%). RXRX quarterly short term debt is now -1.58% below its all-time high of $16.72 million, reached on June 30, 2024.RXRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXRX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | +169.0% |
| 3 y3 years | +299.8% | +172.0% |
| 5 y5 years | +1031.8% | +172.0% |
RXRX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +308.8% | -1.6% | +992.4% |
| 5 y | 5-year | at high | +1031.8% | -1.6% | +993.9% |
| alltime | all time | at high | +1031.8% | -1.6% | +993.9% |
Recursion Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.45 M(-1.6%) |
| June 2024 | - | $16.72 M(+173.3%) |
| Mar 2024 | - | $6.12 M(-0.6%) |
| Dec 2023 | $6.16 M(+1.8%) | $6.16 M(+1.8%) |
| Sept 2023 | - | $6.05 M(+2.6%) |
| June 2023 | - | $5.89 M(+15.6%) |
| Mar 2023 | - | $5.10 M(-15.7%) |
| Dec 2022 | $6.05 M | $6.05 M(+7.3%) |
| Sept 2022 | - | $5.64 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $5.33 M(+27.7%) |
| Mar 2022 | - | $4.18 M(+177.4%) |
| Dec 2021 | $1.51 M(-2.2%) | $1.51 M(+0.1%) |
| Sept 2021 | - | $1.50 M(-58.6%) |
| June 2021 | - | $3.63 M(+37.4%) |
| Mar 2021 | - | $2.64 M(+71.7%) |
| Dec 2020 | $1.54 M(+183.1%) | - |
| Dec 2020 | - | $1.54 M |
| Dec 2019 | $544.00 K | - |
FAQ
- What is Recursion Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual short term debt year-on-year change?
- What is Recursion Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly short term debt year-on-year change?
What is Recursion Pharmaceuticals annual short term debt?
The current annual short term debt of RXRX is $6.16 M
What is the all time high annual short term debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual short term debt is $6.16 M
What is Recursion Pharmaceuticals annual short term debt year-on-year change?
Over the past year, RXRX annual short term debt has changed by +$108.00 K (+1.79%)
What is Recursion Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of RXRX is $16.45 M
What is the all time high quarterly short term debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly short term debt is $16.72 M
What is Recursion Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, RXRX quarterly short term debt has changed by +$10.34 M (+168.96%)